Herbert Kuhl

Add links
From Wikipedia, the free encyclopedia
Herbert Kuhl
A photo of Kuhl taken from a 1999 paper[1]
Born1940 (age 83–84)
Aschaffenburg, Germany
NationalityGerman
EducationGoethe University Frankfurt: chemistry and biochemistry (1961–1967); doctorate in biochemistry and pharmacy (1972); postdoctoral qualification in human medicine for the subject of experimental endocrinology (1977)[1]
Occupation(s)Gynecologist; Medical researcher
Years active1970[2]–present
Medical career
ProfessionProfessor, physician
InstitutionsDepartment of Obstetrics and Gynecology, J. W. Goethe University of Frankfurt; Universitäts-Frauenklinik in Frankfurt
ResearchGynecology

Herbert Kuhl is a German gynecologist who has published extensively in the areas of estrogens, progestogens, menopause, hormonal contraception, and menopausal hormone therapy.[1] His works include numerous original and review articles and several books.[1] Kuhl is a member of many medical societies and has received various scientific awards.[1]

Among Kuhl's most widely cited publications is his 2005 literature review in the journal Climacteric, Pharmacology of Estrogens and Progestogens: Influence of Different Routes of Administration.[3][4] He has published several articles interpreting the findings of the Women's Health Initiative (WHI) study.[5][6][7][8][9][10][11]

Kuhl was born in Aschaffenburg, Germany in 1940.[1] He was educated at the Goethe University Frankfurt from 1961 to 1977.[1] Kuhl first published in 1970.[2] From 1981, he was a professor at the Universitäts-Frauenklinik (University Women's Clinic) of the Goethe University Frankfurt.[5] Until 2013, Kuhl continued to be affiliated with this institution.[11] Since then however, he has listed no affiliation in his publications except that he resides in Aschaffenburg, Germany.[12][13]

Selected publications[edit]

Books[edit]

Authored books[edit]

  • Kuhl, Herbert; Taubert, Hans-Dieter (1987). Das Klimakterium – Pathophysiologie, Klinik, Therapie [The Climacteric – Pathophysiology, Clinic, Therapy] (in German). Stuttgart, Germany: Thieme Verlag. ISBN 978-3137008019. OCLC 19780387. OL 31949169M. (1st and only edition)
  • Hans-Dieter Taubert; Herbert Kuhl (1995). Kontrazeption mit Hormonen: ein Leitfaden für die Praxis [Hormonal Contraception: A Practical Guide] (in German) (2 ed.). Stuttgart, Germany: Thieme. ISBN 978-3-13-608802-9. OCLC 1068026728. (1st edition published in 1981)
  • Herbert Kuhl; Claudia Jung-Hoffman (1999). Kontrazeption [Contraception] (in German) (2 ed.). Georg Thieme Verlag. ISBN 978-3131179920. OCLC 237359985. OL 12671120M. (1st edition published in 1996)
  • Kuhl, Herbert; Wiegratz, Inka (1 January 2008). Klimakterium, Postmenopause und Hormonsubstitution [Climacteric, Postmenopause and Hormone Replacement] (in German) (4 ed.). UNI-MED-Verlag. ISBN 978-3-83742-043-2. OCLC 553736917. OL 31949179M. (Earlier editions published in 1999 (1st), 2001 (2nd), and 2005/2006 (3rd))
  • Inka Wiegratz; Herbert Kuhl (2010). Langzyklus [Long Cycle] (in German). Georg Thieme Verlag. ISBN 978-3-13-153301-2. OCLC 649505497. (1st and only edition)

Edited books[edit]

Book chapters[edit]

Journal articles[edit]

Reviews[edit]

Studies[edit]

Theses/dissertations[edit]

References[edit]

  1. ^ a b c d e f g Kuhl H (1999). "Östrogene für den Mann?" [Estrogens for the Man?]. Journal für Menopause [Ausgabe für Österreich]. 6 (2): 15–23. ISSN 1025-6873.
  2. ^ a b Taubert, H.-D.; Heil, H.; Kuhl, H. (1970). "Untersuchungen über die Wirkung von Äthynil-Oestradiol auf die L-Cystin-Aminopeptidosen-Aktivität im Hypothalamus der weiblichen Ratte" [Investigations on the Effect of Ethynil-Oestradiol on L-Cystine-amino-peptidase Activity in the Hypothalamus of Female Rats]. In Kracht, Joachim (ed.). Endokrinologie der Entwicklung und Reifung: 16. Symposion, Ulm, 26.-28. Februar 1970. Symposion der Deutschen Gesellschaft für Endokrinologie. Vol. 16. Berlin/Heidelberg/New York: Springer-Verlag. pp. 288–289. doi:10.1007/978-3-642-80591-2. ISBN 978-3-642-80591-2. OCLC 863921711.
  3. ^ Kuhl, H (August 2005). "Pharmacology of estrogens and progestogens: influence of different routes of administration" (PDF). Climacteric. 8 (Suppl 1): 3–63. doi:10.1080/13697130500148875. eISSN 1473-0804. ISSN 1369-7137. PMID 16112947. S2CID 24616324.
  4. ^ "Web of Science". Clarivate. Retrieved 19 August 2022.
  5. ^ a b Kuhl H (2003). "Die unterschätzte Bedeutung der Gestagene bei der Hormonsubstitution" [The Underestimated Importance of Progestins in Hormone Replacement Therapy]. Journal für Menopause [Ausgabe für Österreich]. 10 (3): 6–12. ISSN 1025-6873.
  6. ^ Wiegratz I, Kuhl H (August 2004). "Progestogen therapies: differences in clinical effects?". Trends Endocrinol Metab. 15 (6): 277–85. doi:10.1016/j.tem.2004.06.006. PMID 15358281. S2CID 35891204.
  7. ^ Mueck, A. O.; Kuhl, H.; Braendle, W. (September 2004). "Ergebnisse und Kommentare zu der WHI-Studie mit Estrogen-Monotherapie" [Results of and Comments on the WHI Study with Estrogen Monotherapy]. Geburtshilfe und Frauenheilkunde (in German). 64 (9): 917–922. doi:10.1055/s-2004-821217. eISSN 1438-8804. ISSN 0016-5751. S2CID 71579060.
  8. ^ Kuhl H (September 2004). "Is the elevated breast cancer risk observed in the WHI study an artifact?". Climacteric. 7 (3): 319–22. doi:10.1080/13697130400003337. PMID 15669557.
  9. ^ Kuhl H (May 2005). "Breast cancer risk in the WHI study: the problem of obesity". Maturitas. 51 (1): 83–97. doi:10.1016/j.maturitas.2005.02.018. PMID 15883113.
  10. ^ Kuhl H, Stevenson J (June 2006). "The effect of medroxyprogesterone acetate on estrogen-dependent risks and benefits--an attempt to interpret the Women's Health Initiative results". Gynecol Endocrinol. 22 (6): 303–17. doi:10.1080/09513590600717368. PMID 16785155. S2CID 25260381.
  11. ^ a b Kuhl, H.; Schneider, H. P. G. (20 February 2013). "Progesterone – promoter or inhibitor of breast cancer". Climacteric. 16 (Suppl 1): 54–68. doi:10.3109/13697137.2013.768806. eISSN 1473-0804. ISSN 1369-7137. PMID 23336704. S2CID 20808536.
  12. ^ Kuhl, Herbert; Wiegratz, Inka (10 April 2017). "Das Post-Finasterid-Syndrom" [Post-finasteride syndrome]. Gynäkologische Endokrinologie (in German). 15 (2): 153–163. doi:10.1007/s10304-017-0126-2. eISSN 1610-2908. ISSN 1610-2894. S2CID 207071180.
  13. ^ Kuhl, H.; Wiegratz, I. (1 February 2021). "Pharmakokinetik und Pharmakodynamik der in der assistierten Reproduktion verwendeten Gestagene" [Pharmacokinetics and pharmacodynamics of progestogens used in assisted reproduction]. Gynäkologische Endokrinologie (in German). 19 (2): 105–117. doi:10.1007/s10304-020-00372-5. eISSN 1610-2908. ISSN 1610-2894. S2CID 231744549.
Retrieved from "https://en.wikipedia.org/w/index.php?title=Herbert_Kuhl&oldid=1161134277"